These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38651228)

  • 1. Letter to the Editor: A Discussion About Pharmacovigilance Study Methods.
    Lee J
    J Korean Med Sci; 2024 Apr; 39(15):e142. PubMed ID: 38651228
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor concerning the article: 'Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA adverse event reporting system (FAERS)'.
    Sinvhal R; Krueger WS; Kilpatrick RD; Coppola D
    Br J Clin Pharmacol; 2023 Aug; 89(8):2639-2641. PubMed ID: 37114281
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP
    Montastruc F; Bagheri H; Lacroix I; Damase-Michel C; Chebane L; Rousseau V; Jouanjus E; Lapeyre-Mestre M; Durrieu G; Montastruc JL
    Drug Saf; 2018 May; 41(5):511-514. PubMed ID: 29270770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.
    Oosterhuis I; van Hunsel FP; van Puijenbroek EP
    Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.
    Sabblah GT; Darko DM; Mogtari H; Härmark L; van Puijenbroek E
    Drug Saf; 2017 Oct; 40(10):911-921. PubMed ID: 28653291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries.
    Worakunphanich W; Youngkong S; Suwankesawong W; Anderson C; Thavorncharoensap M
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholders' knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study.
    Riordan DO; Kinane M; Walsh KA; Shiely F; Eustace J; Bermingham M
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1363-1372. PubMed ID: 32507924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feedback for patients reporting adverse drug reactions; satisfaction and expectations.
    Rolfes L; van Hunsel F; van Grootheest K; van Puijenbroek E
    Expert Opin Drug Saf; 2015 May; 14(5):625-32. PubMed ID: 25766456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to the Letter to the Editors by Raschi et al: "Antipsychotics and Drug-Associated Liver Injury: Toward Minimum Requirements in Reporting Pharmacovigilance Studies".
    Zeiss R; Gahr M
    J Clin Psychopharmacol; 2023 Jan-Feb 01; 43(1):83-84. PubMed ID: 36441006
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study.
    Zhang X; Niu R; Feng B; Guo J; Liu Y; Liu X
    Expert Opin Drug Saf; 2019 Jan; 18(1):59-68. PubMed ID: 29883236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of adverse drug reaction reporting in Iran: Correction for underreporting.
    Khalili M; Mesgarpour B; Sharifi H; Golozar A; Haghdoost AA
    Pharmacoepidemiol Drug Saf; 2021 Aug; 30(8):1101-1114. PubMed ID: 33772938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of Adverse Events in Colombia: A Successful Case.
    Moreno-Mattar O; Ramírez R; Alvarado A; Sierra F; Guzmán J
    Curr Drug Saf; 2019; 14(1):53-56. PubMed ID: 30411692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improving adverse drug reaction reporting by general practitioners through clinical research assistants visits].
    Durrieu G; Jacquot J; Baudrin D; Mège M; Rousseau V; Bagheri H; Bondon-Guitton E; Abadie D; Montastruc F; Bismuth M; Oustric S; Montastruc JL
    Therapie; 2017 Jun; 72(3):351-355. PubMed ID: 27865436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
    Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G;
    Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public Perspectives of Using Social Media Data to Improve Adverse Drug Reaction Reporting: A Mixed-Methods Study.
    Bulcock A; Hassan L; Giles S; Sanders C; Nenadic G; Campbell S; Dixon W
    Drug Saf; 2021 May; 44(5):553-564. PubMed ID: 33582973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.
    O'Callaghan J; Griffin BT; Morris JM; Bermingham M
    BioDrugs; 2018 Jun; 32(3):267-280. PubMed ID: 29721705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit].
    Batel-Marques F; Mendes D; Alves C; Penedones A; Dias P; Martins A; Santiago LM; Fontes-Ribeiro C; Caramona M; Macedo T
    Acta Med Port; 2015; 28(2):222-32. PubMed ID: 26061513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of patient reporting to the pharmacovigilance system: a systematic review.
    Inácio P; Cavaco A; Airaksinen M
    Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.
    Salehi T; Seyedfatemi N; Mirzaee MS; Maleki M; Mardani A
    Biomed Res Int; 2021; 2021():6630404. PubMed ID: 33937402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.